Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul L McCormack

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Drugs|March 11, 2014
Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastasesMatt Shirley, Paul L McCormack
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 6, 2015
Perindopril/amlodipine (Prestalia(®)): a review in hypertensionMatt Shirley, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2010
Basiliximab: a review of its use as induction therapy in renal transplantationKate McKeage, Paul L McCormack
Drugs|April 11, 2013
Pomalidomide: first global approvalShelley Elkinson, Paul L McCormack
Drugs|May 21, 2010
OfatumumabMark Sanford, Paul L McCormack
CNS Drugs|August 20, 2009
AsenapineJuliane Weber, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 13, 2008
Panitumumab: in metastatic colorectal cancer with wild-type KRASJuliane Weber, Paul L McCormack
Drugs|September 10, 2011
Eldecalcitol: a review of its use in the treatment of osteoporosisMark Sanford, Paul L McCormack
Drugs|December 17, 2013
Obinutuzumab: first global approvalFiona Cameron, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 27, 2004
Etanercept: in ankylosing spondylitisPaul L McCormack, Keri Wellington
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Drugs|March 11, 2014
Radium-223 dichloride: a review of its use in patients with castration-resistant prostate cancer with symptomatic bone metastasesMatt Shirley, Paul L McCormack
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 6, 2015
Perindopril/amlodipine (Prestalia(®)): a review in hypertensionMatt Shirley, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 9, 2010
Basiliximab: a review of its use as induction therapy in renal transplantationKate McKeage, Paul L McCormack
Drugs|April 11, 2013
Pomalidomide: first global approvalShelley Elkinson, Paul L McCormack
Drugs|May 21, 2010
OfatumumabMark Sanford, Paul L McCormack
CNS Drugs|August 20, 2009
AsenapineJuliane Weber, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 13, 2008
Panitumumab: in metastatic colorectal cancer with wild-type KRASJuliane Weber, Paul L McCormack
Drugs|September 10, 2011
Eldecalcitol: a review of its use in the treatment of osteoporosisMark Sanford, Paul L McCormack
Drugs|December 17, 2013
Obinutuzumab: first global approvalFiona Cameron, Paul L McCormack
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 27, 2004
Etanercept: in ankylosing spondylitisPaul L McCormack, Keri Wellington
Pageof 12